131 Results for "

platelet-activating factor

" in MedChemExpress (MCE) Product Catalog:
Products (131)

131 Results for "platelet-activating factor" in MCE Product Catalog:

43
43 Publications Verification
Cat. No.: HY-108635
CAS No.: 74389-68-7
Purity:  99.85%
Synonyms: PAF (C16)
C16-PAF (PAF (C16)), a phospholipid mediator, is a platelet-activating factor and ligand for PAF G-protein-coupled receptor (PAFR). C16-PAF exhibits anti-apoptotic effect and inhibits caspase-dependent death by activating the PAFR. C16-PAF is a potent MAPK and MEK/ERK activator. C16-PAF induces increased vascular permeability .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-N0784
CAS No.: 15291-77-7
Synonyms: BN-52021
Ginkgolide B (BN-52021), a terpene lactone, is a potent platelet activating factor antagonist. Ginkgolide B protects endothelial cells via the activation of PXR from injuries induced by xeno- and endobiotics. Ginkgolide B can pass through the brain-blood barrier. Ginkgolide B has anti-oxidant, anti-inflammatory, anti-tumor, and anti-apoptotic activity. Ginkgolide B has marked neuroprotective effects against ischemia-induced impairments .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-P1929
CAS No.: 128270-60-0
Bivalirudin, a hirudin analog and anticoagulant, is a direct thrombin inhibitor. Bivalirudin inhibits thrombin-mediated fibrinogen cleavage, coagulation factor activation, and platelet activation by reversibly binding to thrombin. In addition, Bivalirudin also has certain effects of anti-virus, anti-inflammation, and vascular endothelial barrier function protection. Bivalirudin can be used for the research of thrombotic diseases and others .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-15664
CAS No.: 1191386-55-6
Purity:  99.89%
Bivalirudin TFA, a hirudin analog and anticoagulant, is a direct thrombin inhibitor. Bivalirudin TFA inhibits thrombin-mediated fibrinogen cleavage, coagulation factor activation, and platelet activation by reversibly binding to thrombin. In addition, Bivalirudin TFA also has certain effects of anti-virus, anti-inflammation, and vascular endothelial barrier function protection. Bivalirudin TFA can be used for the research of thrombotic diseases and others .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108634
CAS No.: 105219-56-5
Purity:  99.93%
Synonyms: WEB 2086
Apafant (WEB 2086), a chemical probe, is a potent platelet-activating factor (PAF) antagonist, inhibits PAF binding to human PAF receptors with a Ki of 9.9 nM. Apafant increases the gene expression of PAF-r, α-globin, β-globin, decreases the c-myb gene expression. Apafant shows a protective effect on alkyl-PAF-mediated lethalit .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-102004
CAS No.: 412950-08-4
Purity:  99.44%
Synonyms: SB 659032
Rilapladib (SB 659032) is a selective Lp-PLA2 (lipoprotein-associated phospholipase A2) inhibitor with an IC50 of 230 pM . Rilapladib (SB 659032) is also a PAFR (Platelet Activating Factor Receptor) antagonist .
loading...
    loading...
Cat. No.: HY-W027544
CAS No.: 62935-72-2
Synonyms: 7-Methoxycoumarin-4-acetic acid
MCA (7-Methoxycoumarin-4-acetic acid) is a Coumarin (HY-N0709) derivative. MCA quantitates platelet-activating factor (PAF) by high-performance liquid chromatography with fluorescent detection. MCA can modify FRET peptide substrates for analyzing protease activities .
loading...
    loading...
Cat. No.: HY-48917
CAS No.: 15049-93-1
Target:  

Phospholipase Apoptosis

Research Areas:  

Inflammation/Immunology

C10 Bisphosphonate is an acid sphingomyelinase (aSMase) inhibitor with an IC50 of 0.02 μM in rats. C10 Bisphosphonate inhibits Dexamethasone (HY-14648)-induced cell apoptosis (apoptosis) and alleviates platelet-activating factor (PAF)-induced pulmonary edema. C10 Bisphosphonate can be used for the research of pulmonary edema .
loading...
    loading...
Cat. No.: HY-130345
CAS No.: 74389-69-8
Purity:  99.00%
C18-PAF, octadecane PAF, is the ligand of platelet-activating factor and PAF G protein-coupled receptor (PAFR). C18-PAF has renovasodilator properties and antihypertensive lipid properties. C18-PAF increases renal blood flow and causes dose-dependent systemic hypotension .
loading...
    loading...
Cat. No.: HY-N10663
CAS No.: 95851-37-9
Kadsurenone is a lignan with specific antagonistic activity against platelet-activating factor. Kadsurenone can be derived from the stem of Piper kadsura .
loading...
    loading...
Cat. No.: HY-111053
CAS No.: 942285-55-4
Purity:  98.06%
Target:  

Phospholipase

Research Areas:  

Cancer

P11 is a selective inhibitor of platelet-activating factor acetylhydrolases (PAFAHs) 1b2 and 1b3 that impairs cancer cell survival. P11 exhibits IC50 values of ~40 and 900 nM for PAFAH1b2 and 1b3, respectively .
loading...
    loading...
Cat. No.: HY-128694
CAS No.: 136468-36-5
Purity:  99.97%
Synonyms: SR27417
Foropafant (SR27417) highly potent, competitive, selective and orally active antagonist of platelet-activating factor (PAF) receptor, with a Ki value of 57 pM for [ 3H]PAF binding, at least 5-fold lower than that of unlabeled PAF itself. Foropafant potently inhibits PAF-induced aggregation of rabbit and human platelets .
loading...
    loading...
Cat. No.: HY-137257
CAS No.: 91575-58-5
Purity:  ≥99.0%
Synonyms: C-PAF
Carbamyl-PAF is an analog and agonist of platelet-activating factor (PAF). Carbamyl-PAF is not significantly metabolized by Raji lymphoblasts at 37°C, making it a useful tool for inflammation research. .
loading...
    loading...
Cat. No.: HY-108908A
CAS No.: 122957-06-6
Synonyms: UK-80067
Modipafant (UK-80067), the (+)-enantiomer of UK-74505, is a potent, orally active, and selective platelet-activating factor (PAF) antagonist. Modipafant exhibits approximately double the intrinsic potency of UK-74505 .
loading...
    loading...
Cat. No.: HY-114745
CAS No.: 57055-82-0
Purity:  98.3%
Research Areas:  

Cancer

MoTP is a specific platelet activating factor receptor antagonist and can induce melanocyte ablation. MoTP can be used for the research of cancer.
loading...
    loading...
Cat. No.: HY-100164
CAS No.: 114606-56-3
Purity:  99.77%
Synonyms: MKS 492
Research Areas:  

Inflammation/Immunology

SDZ-MKS 492 (MKS 492) is a selective inhibitor of cyclic GMP-inhibited phosphodiesterase (type III PDE). SDZ-MKS 492 inhibits antigen- or platelet activating factor (PAF)-induced bronchoconstriction and allergic reactions in guinea pigs and rats .
loading...
    loading...
Cat. No.: HY-N2892
CAS No.: 97399-91-2
Synonyms: Aristololactam A IIIa; Sch 546909
Aristolactam A IIIa (Sch 546909) is an aristolactam-type alkaloid that can be isolated from Glycosmis chlorosperma. Aristolactam A IIIa is a DYRK1A Inhibitor. Aristolactam A IIIa inhibits platelet aggregation induced by arachidonic acid (AA), collagen and platelet-activating factor (PAF). Aristolactam A IIIa has strong cytotoxic effect on HeLa cells .
loading...
    loading...
Cat. No.: HY-105198
CAS No.: 139133-26-9
Synonyms: BB-882
Lexipafant is a platelet-activating factor (PAF) antagonist that inhibits the inflammatory response and is used in the research of acute pancreatitis.
loading...
    loading...
Cat. No.: HY-101833
CAS No.: 131888-54-5
Purity:  99.24%
YM-264 is a selective, potent and orally active platelet-activating factor (PAF) antagonist with a pKi value of 8.85 for rabbit platelet membranes.
loading...
    loading...
Cat. No.: HY-141570S
CAS No.: 201216-37-7
Purity:  ≥99.0%
Synonyms: Lyso-platelet-activating factor C-16-d4
Lyso-PAF C-16-d4 (Lyso-platelet-activating factor C-16-d4) is the deuterated-labeled Lyso-PAF C-16 (HY-141570). Lyso-PAF C-16 is a precursor and metabolite of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (PAF C-16). Lyso-PAF C-16 is a substrate for either PAF C-16 formation by the remodeling pathway or selective acylation with arachidonic acid by a CoA-independent transacylase .
loading...
    loading...